Health Condition 1: K040- Pulpitis
Conditions
Interventions
Intervention1: GROUP II- dexamethasone (8mg)
GROUP III-triamcinolone acetonide (40mg): In group 2: 8 mg, 2 ml dexamethasone will be administrated after local anesthesia ,submucosally into the mucobuc
Sponsors
DR PARI ANAND
Eligibility
Inclusion criteria
Inclusion criteria: • Healthy adults aged 18-50 years of age with symptomatic irreversible pulpitis. • Patients with good general health and no chronic systemic diseases. • Patients with a radiographically normal periapical region
Exclusion criteria
Exclusion criteria: • Teeth with periapical pathology, abscess, calcified canals or aberrant anatomy. • Patients with History of allergy to Local anesthesia or any other experimental drugs. • Patients with systemic disorders, pregnant and breastfeeding mothers and any conditions that contradict use of steroids. • Patients with use of analgesics or anti-inflammatory drugs 12 hours prior to the procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| post operative pain using Heft-Parker visual analogue scale (HP VAS)Timepoint: PRE-OP, POST-OP AFTER 6HRS, 12HRS, 24HRS,48HRS AND 72 HRS. | — |
Secondary
| Measure | Time frame |
|---|---|
| POST OPERATIVE PAIN USING Heft-Parker visual analogue scale (HP VAS)Timepoint: PRE-OP,POST-OP AFTER 6HRS, 12HRS,24HRS,48HRS, 72 HRS | — |
Countries
India
Contacts
Public ContactDR PARI ANAND
THE OXFORD DENTAL COLLEGE
Outcome results
None listed